Aptose Biosciences Inc.
Home
About
Overview
Management Team
Board of Directors
Scientific Advisory Board
Product Pipeline
Overview
CG-806 for B-cell Tumors
CG-806 for Myeloid Tumors
APTO-253
Posters & Presentations
Clinical Trials
Overview
CG-806 for CLL & NHL
CG-806 for AML
APTO-253 for AML & MDS
News
Press Releases
Presentations
Events
Investors
Overview
News & Events
Company Info
Financial Info
Stock Data
SEC Filings
SEDAR
Governance
Careers
Contact
IR Calendar
Investors
Investors
Overview
News & Events
Overview
Press Releases
IR Calendar
Email Alerts
Company Info
Overview
Management Team
Presentations
Contacts
Financial Info
Overview
Financial Results
Income Statement
Cash Flow
Stock Data
NASDAQ: APTO
TSX: APS
Analyst Coverage
SEC Filings
Overview
All SEC Filings
Annual Reports
Quarterly Reports
Section 16 Filings
SEDAR
Governance
Overview
Board of Directors
Board Committees
Governance Documents
News & Events
Overview
Press Releases
IR Calendar
Email Alerts
Aptose Corporate Update
Dec 6, 2020 • 2:00 pm PST
Audio
Webcast
Email Alerts
Contacts
RSS News Feed